Teva settles further price-fixing lawsuits in the US

Teva's R&D labs in Netanya  credit: Teva PR
Teva's R&D labs in Netanya credit: Teva PR

Teva will pay a total of $450 million over six years to settle the cases.

Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) has settled another lawsuit alleging price fixing in the US. Teva will pay $450 million in settlements approved by the court in the US, one of $425 million and the other of $25 million, without admitting wrongdoing. Payment of the settlement amounts will be spread over six years.

The first, larger settlement relates to a lawsuit filed by the US Department of Justice against Teva and other companies in 2020, alleging price fixing that led to overpayments totaling $350 million by US consumers. The allegation was that Teva used charities that assist patients in order to increase the use of its then flagship product, Copaxone, a treatment for multiple sclerosis. According to the prosecution, Teva made donations to these charities that would cover patients’ co-payments for Copaxone, in effect using the charities to pay kickbacks to patients for using the drug, contrary to the federal Anti-Kickback Statute. The alleged indirect result was a sharp rise in the price of Copaxone, from $17,000 a year in 2006 to $85,000 in 2017.

The second case, settled for $25 million, concerned further allegations of price fixing in the generic drugs industry. Two years ago, Teva reached a similar settlement in such a case, agreeing to pay a $225 million penalty and to sell pravastatin, a generic treatment for reducing cholesterol and triglycerides, to another company. In addition, Teva undertook to donate $50 million worth of two generic drugs, clotrimazole and tobramycin, to charity.

Two years ago, Teva also reached a settlement in the affair of the sale of opioids, painkillers that caused addiction in some half a million patients in the US. In that case, Teva agreed to pay compensation of $4.25 billion, $3 billion of it in cash.

In the past few years, Teva has taken action to settle many lawsuits, and also to reduce the high leverage that has weighed on it since it acquired Actavis, the generic drug division of Allergan, in 2015.

Since Teva announced the settlement of the opioids case two years ago, its share price has risen by more than 170%, bringing it to a market cap of NIS 75 billion, although this is still far below its peak value of NIS 250 billion.

In this morning’s trading on the Tel Aviv Stock Exchange, Teva’s share price is down 1.55%, at NIS 65.26.

Published by Globes, Israel business news - en.globes.co.il - on October 13, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Teva's R&D labs in Netanya  credit: Teva PR
Teva's R&D labs in Netanya credit: Teva PR
Arik Faingold credit: Nati Levi Israeli autonomous frontend co AutonomyAI raises $4m

Led by Arik Faingold, the founder of cybersecurity unicorn Pentera, AutonomyAI offers a platform that learns and understands the full organizational context and generates code that can be deployed directly to the production environment.

British Airways aircraft  credit: Shutterstock/Jarek Kilian Tel Aviv - London fares to fall as British Airways resumes flights

From June there will be 20-32 weekly flights operated on the popular Tel Aviv - London route by foreign airlines - British Airways, Wizz Air and easyJet.

Partner Partner forms int'l business diivision

The division will be headed by former Bezeq International VP Global Business Nissan Arieh.

Caesarstone kitchen credit: Caesarstone Caesarstone bucks Nasdaq as tariffs boost potential

The Israeli quartz countertop manufacturer company has fallen on hard times due to Chinese rivalry but tariffs could boost its revenue.

ZIM ship credit: ZIM Trump's tariffs torpedo ZIM's share price

ZIM's share price fell 16.4% on Wall Street on Thursday and a further 7.2% on Friday, closing with a market cap of $1.5 billion, wiping out all its gains in 2025.

Israeli apartments Credit: Shutterstock Apartments sold and rented

A selection of recent real estate deals in Israel in Tel Aviv, Holon, Rehovot, Kiryat Tivon, Shlomi and Beersheva.

THAAD anti missile system credit: The US Army Ralph Scott Wikimedia US deploys more THAAD, Patriot batteries in Israel - report

Amid rising regional tensions the US is bolstering Israel's air defense, Saudi state-owned TV channel Al Arabiya reports.

Tel Aviv Stock Exchange credit: Shutterstock TASE tumbles in Wall Street's wake

Dual-listed stocks have again been hard hit, but the banks are also down sharply.

Donald Trump and Benjamin Netanyahu credit: Avi Ohayon Netanyahu due in Washington to discuss tariffs

According to news website Axios, Prime Minister Benjamin Netanyahu will be the first leader to meet President Trump after the latter's announcement of sweeping import tariffs.

Yoni Assia CEO eToro Credit: PR eToro defers IPO amid market turmoil

The online trading platform had planned to begin meetings with investors this week.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef Smotrich meets wrong man in Washington

Minister of Finance Bezalel Smotrich tried to persuade Secretary of the Treasury Scott Bessent to soften the tariff blow on Israel - only Bessent isn't responsible for the matter.

Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018